Treatment of macrophage-related disorders
US9579346B2 · kind B2 · utility
12Cited by
7References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 6, 2014 |
| Grant date | Feb 28, 2017 |
| Priority date | — |
| Expiry date | May 6, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of treating a macrophage related disease comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The present invention also provides a method of modulating macrophage accumulation or activation comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The oxidative agent can be chlorite or a chlorite containing compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.